For decades, one of the brightest lines in brokerage regulation was FINRA Rule 2210(d)(1)(F): broker-dealers were strictly prohibited from predicting or projecting investment performance in communications with the public, subject to only a handful of narrow technical carve-outs.

That landscape is shifting. Following the SEC’s October 15, 2026 approval of SR-FINRA-2026-004 (Exchange Act Release No. 34-106675) and FINRA’s October 21, 2026 publication of Regulatory Notice 26-19 amending FINRA Rules 5123 and 5110, broker-dealers and placement agents are gaining new flexibility to present projected performance and targeted returns and to sell certain private placements without filing offering documents with FINRA.

At the same time, FINRA’s latest late-October and early-November 2026 firm enforcement actions—including a $250,000 fine against Apex Clearing Corporation for margin-supervision failures and an $800,000 fine against Revere Securities LLC over small-cap IPO and anti-money laundering (AML) breakdowns—show just how quickly investors can get burned when brokerage supervision fails to keep pace with sales practices.

Here is a closer look at FINRA’s newest rule changes, the latest firm-level enforcement actions, and how investors can spot the difference between a compliant presentation and an actionable misrepresentation.

1. FINRA Rule 2210(d)(1)(F)(iv): Brokers Can Soon Pitch “Projected Performance” and “Targeted Returns”

Historically, SEC-registered investment advisers had limited leeway under the SEC’s Marketing Rule (Advisers Act Rule 206(4)-1) to show hypothetical performance to certain prospects, while FINRA-registered broker-dealers selling the exact same private fund were barred from sharing performance projections or targeted returns.

Under newly approved FINRA Rule 2210(d)(1)(F)(iv) (which will take effect on a date FINRA announces in an upcoming Regulatory Notice), broker-dealers may include projected performance (estimates of future performance based on historical data, assumptions, or mathematical modeling) and targeted returns (aspirational performance goals) for a security, portfolio, asset allocation, or strategy—but only if strict conditions are met:

  • Restricted Audience (Not for General Retail Circulation): The broker-dealer must adopt and implement written policies and procedures reasonably designed to ensure the communication is relevant to the likely financial situation and investment objectives of the intended audience. In its rulemaking record, FINRA emphasized that projections and target returns should only be distributed to investors whom the firm reasonably believes have the financial expertise to understand the risks and limitations of projections and access to resources to independently analyze the information. It does not permit projections in mass-market retail advertisements.
  • Mandatory Disclosures of Assumptions and Risks: The broker must provide clear disclosures explaining the criteria and assumptions underlying the projection or target return, as well as the material risks and limitations of relying on those figures to make an investment decision.
  • Recordkeeping & Sound Basis Requirements: Firms must retain records identifying the source of the projections or targeted returns. While FINRA removed a standalone “reasonable basis” clause in Partial Amendment No. 1 during the rulemaking process, it emphasized that all projections remain governed by Rule 2210’s core content standards—meaning communications must be fair and balanced, provide a sound basis for evaluating the facts, and never include false, exaggerated, unwarranted, promissory, or misleading claims.
  • What Remains Off-Limits: Notably, FINRA did not extend this new Rule 2210 exception to back-tested performance, model portfolio performance, related performance, or extracted performance.

Why This Matters for Investors With $100,000+ Accounts

Simply meeting the net-worth or income threshold of an “accredited investor” does not automatically mean you have the institutional resources to independently audit a private fund’s mathematical modeling or cash-flow assumptions. If a broker or placement agent pitches you a high-fee private placement, non-traded REIT, or alternative fund using an aggressive “12% to 15% targeted return” slide deck without a sound factual basis, omits key fee assumptions, or treats an aspirational target like a safe yield, that presentation may still violate FINRA Rule 2210, SEC Regulation Best Interest (Reg BI), and FINRA Rule 2010.

2. Regulatory Notice 26-19: Expanded Private Placement Exemptions Under FINRA Rule 5123

Alongside the Rule 2210 changes, FINRA published Regulatory Notice 26-19 on October 21, 2026, announcing amendments to FINRA Rule 5123 (Private Placements of Securities) and FINRA Rule 5110 (Corporate Financing Rule):

  • Rule 5123 Private Placement Changes (Effective October 21, 2026): Rule 5123 generally requires member firms selling private placements to file the private placement memorandum (PPM), term sheet, or other offering documents with FINRA within 15 calendar days of the first sale. The newly effective amendments expand the filing exemptions to include offerings sold to certain entities owning more than $5 million in investments and qualifying family offices (and their “family clients”) with more than $5 million in assets under management.
  • Rule 5110 Underwriting Compensation Changes (Effective December 21, 2026): Updates how securities acquired as underwriting compensation are valued and adds exclusions for certain debt-for-equity exchanges and capital investments in direct participation programs (DPPs) and unlisted REITs.

The Investor Takeaway: Even when a private placement is exempt from FINRA’s Rule 5123 filing requirement—or sold to a family office or $5M+ entity—the brokerage firm is never exempt from its duty to conduct reasonable due diligence on the issuer, verify the offering’s legitimacy, and ensure the recommendation is suitable and free from undisclosed conflicts of interest.

3. Breaking Firm Enforcement Actions: How Supervisory Gaps Hurt Investors

Rules on paper only protect investors when brokerage firms enforce them. Three recent FINRA firm-level disciplinary actions announced in October and early November 2026 highlight the exact types of supervisory breakdowns that frequently appear in investor arbitration claims:

A. Apex Clearing Corporation Fined $250,000 for Margin Account Supervision Failures (Reported November 4–5, 2026)

In a settlement reported in early November 2026, Apex Clearing Corporation consented to a censure and a $250,000 fine (without admitting or denying the findings) for violating FINRA Rules 3110 (Supervision), 4210 (Margin Requirements), and 2010, as well as Federal Reserve Regulation T.

  • What FINRA Found: From at least January 2020 through June 2022, more than 270,000 retail customers introduced to Apex by other broker-dealers held multiple margin accounts through the same introducing firm—totaling roughly 712,000 margin accounts. About 61,000 of those customers carried margin balances across 152,000 separate accounts, and roughly 18,000 customers held three or more margin accounts.
  • The Supervisory Gap: Until January 2023, Apex monitored each margin account in isolation rather than aggregating a single customer’s margin positions, balances, and intraday trading across multiple accounts at the same introducing firm. As a result, Apex could not reasonably monitor whether a customer’s combined intraday transactions breached FINRA Rule 4210 margin limits before remediating its systems and moving accounts to a master-subaccount structure.

B. Revere Securities LLC Fined $800,000 Over Foreign Small-Cap IPO “Ramp-and-Dump” Red Flags (October 2026)

In October 2026, FINRA fined Revere Securities LLC $800,000 and ordered the firm to retain an independent compliance consultant for AML and supervisory failures tied to small-cap initial public offerings (IPOs) for foreign-based issuers (without admitting or denying the findings).

  • What FINRA Found: FINRA found that Revere served as lead underwriter or selling group member for foreign small-cap IPOs that bore hallmarks of potential “ramp-and-dump” manipulation schemes. In one offering, Revere allocated more than $1.5 million in IPO shares—nearly its entire allotment—to just eight customers referred by a foreign broker-dealer. Four of those account holders claimed to be unemployed while reporting over $200,000 in annual income, and seven of the eight applications contained contradictory information about the source of funds. On IPO day, the stock surged 318% before collapsing more than 80%, leaving ordinary market buyers holding the bag.

C. October 2026 FINRA Firm Fines for Escrow Releases, AML Gaps, and Options Coding

FINRA’s October 2026 Monthly Disciplinary Report (highlighted in early November 2026 compliance summaries) also featured several telling firm-level enforcement actions:

  • Premature Release of Private Offering Escrow Funds ($50,000 Joint Fine): Sustained following SEC review, a firm and its CEO were sanctioned for releasing investor funds from an offering’s escrow account before the offering had raised its required minimum contingency amount from bona fide investors.
  • Unmonitored Money Movements & Missing Form CRS Delivery ($125,000 Fine): A firm was fined after its AML surveillance system failed to flag suspicious money movements outside of outgoing wires—closing review alerts within seconds without inquiry, including transfers from a business account to a trust account and then to a foreign currency exchange—while also failing to confirm delivery of Form CRS to certain retail customers.
  • Unreported Fractional-Share Liquidations ($125,000 Fine) & Options Order Coding Errors ($115,000 Fine): Separate firms were sanctioned for failing to report 2.56 million fractional-share dividend reinvestment liquidations and failing to apply required “Professional Customer” origin codes on options orders.

4. Five Red Flags Investors Should Watch For in Late 2026 and 2027

Whether you are evaluating a new private placement pitch or reviewing heavy losses in your existing portfolio, keep these five questions front and center:

  1. Were You Shown a “Targeted Return” Without the Underlying Math? If a broker pitched you a private fund, real estate syndicate, or alternative strategy using projected yields or targeted returns, did they disclose the specific fee drag, leverage assumptions, and downside scenarios—or did they present the target return as a near-certainty?
  2. Were You Treated as an “Institutional” or “Sophisticated” Investor on Paper Only? Having a high net worth or a family trust does not give a broker a free pass to sell you unvetted, illiquid private placements without explaining the lockup risks.
  3. Were Offering Proceeds Released Before the Minimum Raise Was Met? In contingent private offerings (“all-or-none” or “part-or-none”), releasing your escrow funds before the minimum threshold is raised from genuine investors is a serious securities violation.
  4. Did Your Firm Let Margin Debt or Concentrated Risk Spiral Across Multiple Accounts? As recent FINRA actions and high-value arbitrations show, improperly monitored margin accounts and securities-backed lines of credit (LALs/SBLOCs) can trigger catastrophic forced liquidations during market swings.
  5. Were You Sold a hyped Small-Cap Stock That Suddenly Collapsed? Rapid “ramp-and-dump” schemes in thinly traded small-cap equities continue to be one of FINRA’s top enforcement priorities in 2026.

Recovering Investment Losses Through FINRA Arbitration

When FINRA fines a brokerage firm $250,000 or $800,000 for supervisory failures, that penalty is paid to the regulator—not to the investors who lost money. However, the exact rules cited in these regulatory actions—such as FINRA Rule 2210 (Communications with the Public), FINRA Rule 3110 (Supervision), SEC Regulation Best Interest (Reg BI), and FINRA Rule 4210 (Margin Requirements)—often serve as critical building blocks in private FINRA arbitration claims brought by harmed investors.

Disclaimer: This article summarizes recent SEC and FINRA rulemakings and settled FINRA disciplinary actions (in which respondents consented to findings without admitting or denying the allegations) based on public regulatory records as of November 5, 2026. It is provided for general informational purposes only and does not constitute legal advice.

Official Sources